The Best CEO in Pharma

sounds like you know the culprits so name them !

 

Moron, missed the point
Pharma is a risky business
There are no culprits
Blank is doing an excellent job; Squidlaco same.

So if you know more, then have the gonads to post otherwise be silent and let Acorda be successful

 

VelociRon is the primary culprit. He approved the licensing. He approved the development plans. He approved the IP strategy. He approved the current regulatory strategy. He has not grown the value of ACOR. He is the one that people can’t speak the truth to.

 

Our CEO is doing a great job.

 

Goldberg is also doing a great job.

 

Bernstein is also doing a great job.

 

So much BS in this CP Thread.
Now we get the usual senseless statement, follow by the anti-Habib posts.
Gargabe, plain and simple garbage
Let ACOR alone.

 

Our CEO is already in the office. at. 5 am. He loves seeing. title of this .thread.

 

Very. unfair to blame your CEO as many of his 'approvals' were not his option as his hands were tied.
at least tell the accurate historical facts. There is much finger pointing at wrong person!!!

 

Your CEO in office at 5am today..

 

Your CEO. loves the title of this thread!

 

No more postings so back to work

 

So let me get this straight Habib.

VelociRon has no decision making ability but we are to laud him for his genius and hard work? The picture you have painted is that of a puppet and figure head.

That’s a pretty nice paycheck to just show up and have no control or accountability.

As for facts, you are presented with the facts routinely. This usually entails another of your redirections about multi. Dimensional Dungeons and Dragons with the AI recreation of Karl Marx.

You can’t have it both ways Habib. Either Ronnie is a misunderstood genius steering ACOR to greatness (and responsible along the way) or he is a bloviating figurehead with no responsibility or accountability.

 

Short answer: yes we should as you say 'laud him for his genius and hard work', but of course he is accountable for the great results and occasional disappointments. Unfortunately our CEO has been disadvantaged by subordinates who dropped the ball (recall the intern fiasco?).

The inflection point has been passed; we are on the uptick with the new pipeline ballbusters and accelerated approvals. Lessons learned from the six sigma zero defect study a year ago also have helped re-educate sales team leads.

 

[QUOTE="....The inflection point has been passed; we are on the uptick ......[/QUOTE]

UPTICK?

With Goldman leaving, stock down 14%, the only TICK on Acorda, unfortunately has Lyme disease.

What the F$%^ are we doing in HQ to bring this Approval home?
Are we already on Label negotiations or not?

 

UPTICK?

With Goldman leaving, stock down 14%, the only TICK on Acorda, unfortunately has Lyme disease.

What the F$%^ are we doing in HQ to bring this Approval home?
Are we already on Label negotiations or not?[/QUOTE]

please calm down. everything is under control ! you do not have a need to know !

 

Well Habib I will definitely give it to you. That is quite a bit of BS, buzzwords and flat out lies packed into a few sentences.

VelociRon is responsible for his subordinates, their work and the plans. There has been one positive outcome. The approval of Ampyra 9 years ago. Since then it Phase been one failure after another.

There are no accelerated approvals happening for Me2 LD. The countries you bring up don’t even have a mechanism for it and the ones who do still haven’t approved it.

Obviously the six sigma charade didn’t work in R&D. If you think it has applications to the field, you may want to brush up on it again.

As for inflection points, you haven’t had a meaningful inflection in two years other than an indication to sell what is left of the company.

BTW, $16 is hardly an uptick.

 

I bust my ass here on the Field West Coast!!!

I DO HAVE A RIGHT TO KNOW

HQ idiots

 

But it was up 1.3% today !!!! Yes we have reached an inflection point and the sky is the limit. Patience my friend, patience !! Our CEO and his ace team have everything under control. Six Sigma did work and may be deployed as part of field sales training as we introduce the pipeline.

 

Sorry Habib I must have missed the WSJ fanfare over the .20 per share price movement. It must have been hidden by all the Harvard Business Review articles on how ACORs six sigma helped them avoid CRLs and further delays.